Loading...
Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment
AIM: Agomelatine (AGM) is the first melatonergic antidepressant. It suffers from low oral bioavailability (<5%) due to extensive hepatic metabolism. The current work aimed to develop an alternative AGM-loaded invasomes to enhance transdermal drug bioavailability. METHODOLOGY: AGM-loaded invasomes...
Saved in:
| Published in: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669507/ https://ncbi.nlm.nih.gov/pubmed/33209023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S283911 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|